Apalutamide is a medicine for prostate cancer. It is taken as a pill by mouth, usually along with hormone therapy. It works by blocking male hormones like testosterone from helping prostate cancer cells grow.
Every report comes from a Lived member, sent anonymously.
Have you tried Erleada (Apalutamide) for Prostate Cancer?
Apalutamide, sold as Erleada, is a prescription pill for prostate cancer. It is approved in two situations. The first is metastatic castration-sensitive prostate cancer: cancer that has spread beyond the prostate but still responds when testosterone is lowered. The second is non-metastatic castration-resistant prostate cancer: cancer that has not shown up elsewhere on scans but keeps advancing, usually seen as a rising PSA (prostate-specific antigen, a blood marker of prostate cancer activity), even though testosterone is already low. Apalutamide is always added to testosterone-lowering treatment, not used in place of it. It belongs to a group of newer anti-androgen medicines that also includes enzalutamide (Xtandi) and darolutamide (Nubeqa). In large trials, adding apalutamide helped people live longer. In cancer that had spread, fewer people died during the study (about a third, compared with nearly half on placebo). In cancer that had not spread, it delayed the cancer's appearance elsewhere in the body by roughly two years on average.
Prostate cancer cells usually depend on male hormones (androgens), especially testosterone, to grow. Standard hormone therapy, called androgen deprivation therapy (ADT), lowers the amount of testosterone the body makes. Even at very low levels, though, cancer cells can still pick up the hormone that remains. Apalutamide works at the next step. It attaches to the androgen receptor, the docking site inside the cancer cell that testosterone acts through, and blocks it from switching on the genes that drive the cell to grow and divide. Lowering testosterone and blocking its receptor together shuts down the hormone signal more fully than either does alone, which slows the cancer. It does not remove cancer that is already there, and over time some cancers find ways around the block.
Erleada is taken by mouth once a day, at about the same time each day, with or without food. Tablets are swallowed whole and should not be crushed or split. For people who cannot swallow tablets, the label describes an approved way to let the tablets break up in water and take them with orange juice, applesauce or more water, or to give them through a feeding tube; the pharmacist or care team can walk through it. The testosterone-lowering treatment, usually a GnRH (gonadotropin-releasing hormone) medicine, needs to continue alongside apalutamide unless the testicles have been surgically removed. Stopping it on your own undoes much of the point of the combination. The dose may be lowered or paused if side effects become hard to tolerate, and a lower dose is used for people with severe liver impairment. If a dose is missed, take it as soon as possible the same day and return to the usual schedule the next day. Do not take extra tablets to make up for it.
The most common side effects are tiredness, joint pain, hot flashes, rash, diarrhea, high blood pressure, lower appetite and weight loss. Rash affects about a quarter of people, typically appearing a few months in. Most rashes are mild to moderate and settle with treatment such as antihistamines or skin creams, sometimes with a pause in the medicine, so it is worth reporting any rash rather than waiting it out. Apalutamide can also slow the thyroid gland, which is checked with blood tests and treated with thyroid hormone if needed. Falls and broken bones are more common, particularly in people over 75, in part because hormone treatment weakens bone. The care team usually assesses fracture risk and may recommend a bone-strengthening medicine. Seizures are uncommon (fewer than 1 in 200 people in trials), but if one happens, apalutamide is stopped for good. Contact the care team right away after any seizure. A few reactions are rare but can be life-threatening. A severe skin reaction can start with fever or flu-like illness and move to a spreading rash, blistering or peeling skin, or sores in the mouth, eyes or genitals. Inflammation of the lungs can show up as new or worsening shortness of breath, cough or fever. For either, stop taking apalutamide and contact the care team right away, or get medical care if you cannot reach them. Heart attacks and strokes were also more frequent in the trials. Chest pain or pressure, or sudden weakness or numbness on one side, trouble speaking or loss of vision, needs emergency care by calling 911.
Apalutamide speeds up the liver enzymes and transporters that clear many other medicines from the body. As a result, some of those medicines can become much weaker. In studies it cut levels of the heartburn medicine omeprazole by more than 80% and lowered levels of the blood thinner warfarin by nearly half. Some cholesterol medicines and many others are affected too. Before starting, review every prescription, over-the-counter medicine and supplement with the prescriber or pharmacist, and check again whenever a new medicine is added. A few medicines can also raise apalutamide levels, which may call for a dose change. People who take digoxin, a heart rhythm medicine, should tell the lab: apalutamide can make some digoxin blood tests read falsely high. Apalutamide can harm a developing baby. Men with a partner who could become pregnant should use effective birth control during treatment and for 3 months after the last dose, and should use a condom with a partner who is already pregnant. It may also reduce fertility, and sperm should not be donated during that same period. Because heart and stroke risk is higher, it helps to keep blood pressure, blood sugar and cholesterol well controlled. People with a history of seizures, or a recent heart attack or stroke, were left out of the main trials, so these deserve a specific conversation before starting.
Apalutamide is a long-term treatment. People generally keep taking it, together with testosterone-lowering therapy, for as long as it keeps the cancer under control and side effects remain manageable. Progress is followed with regular PSA blood tests and periodic scans; a rising PSA or new findings on scans can mean it is time to change approach. Routine visits also check blood pressure, thyroid function, blood sugar and cholesterol, and look out for rash, bone health and fall risk. Side effects such as rash or fatigue often appear in the first months and may ease with time, a dose adjustment or supportive treatment. Tiredness and hot flashes from combined hormone treatment are common. If the cancer eventually grows despite apalutamide, other options include different hormone medicines, chemotherapy and other targeted treatments.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Erleada (Apalutamide), what you've noticed, or ask the community a question.